ANGEL YEAST(SH:600298)2024-10-30 10:09Financial Performance - The company's revenue for Q3 2024 reached CNY 3,737,624,177.49, representing a 27.14% increase compared to the same period last year[4]. - Net profit attributable to shareholders was CNY 262,036,403.67, reflecting a 7.02% increase year-over-year[4]. - The basic earnings per share (EPS) for the quarter was CNY 0.30, up 7.14% from CNY 0.28 in the previous year[5]. - Total operating revenue for the first three quarters of 2024 reached RMB 10,912,241,955.49, an increase of 12.97% compared to RMB 9,653,844,277.91 in the same period of 2023[21]. - Operating profit for the first three quarters of 2024 was RMB 1,156,802,643.93, slightly up from RMB 1,119,678,609.86 in 2023[21]. - Net profit attributable to shareholders of the parent company for the first three quarters of 2024 was RMB 953,163,892.67, compared to RMB 914,504,782.73 in 2023, reflecting a growth of 4.22%[22]. - Net profit for the first three quarters of 2024 was CNY 681,857,855.01, representing a significant increase of 22.73% from CNY 555,360,076.86 in the previous year[30]. - The company's operating profit increased to CNY 700,315,111.24, up 16.67% from CNY 600,200,249.24 in the same period last year[30]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 20,912,297,879.99, an increase of 8.32% from the end of the previous year[5]. - The total assets of Angel Yeast Co., Ltd. increased to CNY 15.69 billion as of September 30, 2024, compared to CNY 13.46 billion at the end of 2023, representing a growth of approximately 16.5%[27]. - The company's total current assets reached CNY 10.71 billion, up from CNY 8.69 billion, indicating a growth of about 23.2%[27]. - Total liabilities reached approximately ¥9.98 billion, compared to ¥8.69 billion, indicating a growth of about 14.9%[19]. - The total liabilities of the company rose to CNY 7.76 billion, up from CNY 5.63 billion, which is an increase of about 37.9%[28]. Cash Flow - Cash flow from operating activities for the year-to-date was CNY 1,118,850,057.14, a decrease of 2.69% compared to the previous year[5]. - The company reported a net cash flow from operating activities of RMB 1,118,850,057.14 for the first three quarters of 2024, a decrease from RMB 1,149,804,853.20 in 2023[24]. - Cash flow from operating activities generated a net amount of CNY 881,838,050.73, down 27.5% from CNY 1,216,118,904.74 in the same period of 2023[32]. - The net cash flow from financing activities was CNY 535.73 million, slightly down from CNY 542.57 million in the previous period[25]. - Cash flow from financing activities resulted in a net outflow of CNY 718,798,882.06, an improvement from a net outflow of CNY 873,718,148.74 in the same period last year[33]. Investments and Acquisitions - The company completed the acquisition of 100% equity in Yichang Angel Biotechnology Co., Ltd. for CNY 20.89 million, enhancing its market position[6]. - Long-term equity investments increased by 42.01% compared to the previous year, primarily due to additional investments in Hubei Weiqi Biotechnology Co., Ltd.[10]. - Cash paid for investments increased by 1033.33% year-on-year, mainly due to significant investments in Hubei Hongyu New Packaging Co., Ltd. and time deposits[11]. - The company reported an increase in investment income to CNY 546,474,139.13, up from CNY 350,831,050.45 in the previous year[30]. Expenses - Cash flow from investing activities showed a net inflow of CNY 205,270,470.32, compared to a net outflow of CNY 172,835,062.01 in the previous year[32]. - Research and development expenses for the first three quarters of 2024 amounted to RMB 435,573,259.77, slightly higher than RMB 427,376,426.87 in 2023[21]. - Sales expenses increased to RMB 580,502,191.53 in the first three quarters of 2024, compared to RMB 507,807,752.88 in the same period of 2023[21]. - The company recorded a financial expense of RMB 44,734,794.90 in the first three quarters of 2024, significantly up from RMB 7,344,286.31 in 2023[21]. - The interest expenses increased to CNY 100,030,850.41, compared to CNY 68,003,444.72 in the same period of 2023[30]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 83,826[14]. - The company's equity attributable to shareholders increased to approximately ¥10.43 billion from ¥10.09 billion, reflecting a growth of about 3.4%[19]. - The company's equity increased to CNY 7.93 billion from CNY 7.83 billion, showing a growth of approximately 1.1%[28].